New drug application 21-628, Certican (everolimus), for the proposed indication of prophylaxis of rejection in heart transplantation: report from the Cardiovascular and Renal Drugs Advisory Committee, US Food and Drug Administration, November 16, 2005, Rockville, Md |
| |
Authors: | Hiatt William R,Nissen Steven E Cardiovascular Renal Drugs Advisory Committee, US Food Drug Administration |
| |
Affiliation: | Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80203, USA. will.hiatt@uchsc.edu |
| |
Abstract: | |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|